CN1243754C - 生产9－氧杂－3,7－二偶氮二环[3.3.1]壬烷的方法 - Google Patents

生产9－氧杂－3,7－二偶氮二环[3.3.1]壬烷的方法 Download PDF

Info

Publication number
CN1243754C
CN1243754C CNB018167225A CN01816722A CN1243754C CN 1243754 C CN1243754 C CN 1243754C CN B018167225 A CNB018167225 A CN B018167225A CN 01816722 A CN01816722 A CN 01816722A CN 1243754 C CN1243754 C CN 1243754C
Authority
CN
China
Prior art keywords
alkyl
aryl
compound
het
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018167225A
Other languages
English (en)
Chinese (zh)
Other versions
CN1468245A (zh
Inventor
J·帕维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/SE2000/001994 external-priority patent/WO2001028992A2/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1468245A publication Critical patent/CN1468245A/zh
Application granted granted Critical
Publication of CN1243754C publication Critical patent/CN1243754C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CNB018167225A 2000-10-02 2001-10-01 生产9－氧杂－3,7－二偶氮二环[3.3.1]壬烷的方法 Expired - Fee Related CN1243754C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PH12000002701 2000-10-02
PH1200002701 2000-10-02
PCT/SE2000/001994 WO2001028992A2 (en) 1999-10-18 2000-10-13 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
SEPCT/SE00/01994 2000-10-13

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA2005100035779A Division CN1793146A (zh) 2000-10-02 2001-10-01 生产9－氧杂－3,7－二偶氮二环[3.3.1]壬烷的新方法

Publications (2)

Publication Number Publication Date
CN1468245A CN1468245A (zh) 2004-01-14
CN1243754C true CN1243754C (zh) 2006-03-01

Family

ID=52573779

Family Applications (3)

Application Number Title Priority Date Filing Date
CNB018167225A Expired - Fee Related CN1243754C (zh) 2000-10-02 2001-10-01 生产9－氧杂－3,7－二偶氮二环[3.3.1]壬烷的方法
CNA018167217A Pending CN1468244A (zh) 2000-10-02 2001-10-01 用于治疗心律失常的新的氧杂桥接哌啶化合物
CNA2005100035779A Pending CN1793146A (zh) 2000-10-02 2001-10-01 生产9－氧杂－3,7－二偶氮二环[3.3.1]壬烷的新方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
CNA018167217A Pending CN1468244A (zh) 2000-10-02 2001-10-01 用于治疗心律失常的新的氧杂桥接哌啶化合物
CNA2005100035779A Pending CN1793146A (zh) 2000-10-02 2001-10-01 生产9－氧杂－3,7－二偶氮二环[3.3.1]壬烷的新方法

Country Status (22)

Country Link
US (5) US6936712B1 (cg-RX-API-DMAC7.html)
EP (3) EP1900741A1 (cg-RX-API-DMAC7.html)
JP (2) JP2004510775A (cg-RX-API-DMAC7.html)
KR (2) KR20030032060A (cg-RX-API-DMAC7.html)
CN (3) CN1243754C (cg-RX-API-DMAC7.html)
AR (1) AR030756A1 (cg-RX-API-DMAC7.html)
AU (3) AU9250401A (cg-RX-API-DMAC7.html)
BR (2) BR0114366A (cg-RX-API-DMAC7.html)
CA (2) CA2421776A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ294217B6 (cg-RX-API-DMAC7.html)
EE (1) EE200300131A (cg-RX-API-DMAC7.html)
HU (1) HUP0302288A3 (cg-RX-API-DMAC7.html)
IL (3) IL154803A0 (cg-RX-API-DMAC7.html)
IS (1) IS6744A (cg-RX-API-DMAC7.html)
MX (2) MXPA03002759A (cg-RX-API-DMAC7.html)
NO (2) NO20031413L (cg-RX-API-DMAC7.html)
NZ (2) NZ524573A (cg-RX-API-DMAC7.html)
PL (1) PL364047A1 (cg-RX-API-DMAC7.html)
RU (1) RU2003107668A (cg-RX-API-DMAC7.html)
SK (1) SK3862003A3 (cg-RX-API-DMAC7.html)
WO (2) WO2002028864A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA200301757B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
GB0223712D0 (en) * 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
CN101243093A (zh) 2005-06-13 2008-08-13 阿斯利康(瑞典)有限公司 用于治疗心律不齐的新型氧杂双哌啶化合物
WO2006137772A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab New physical form of n,n´- disubstituted oxabispidines
WO2006137770A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the preparation of n,n´- disubstituted oxabispidines
AR054391A1 (es) * 2005-06-20 2007-06-20 Astrazeneca Ab Procedimiento para la preparacion de 3,7- dihidroxi-1,5-diazaciclooctanos
BRPI0611841A2 (pt) * 2005-06-20 2016-08-30 Astrazeneca Ab processos para isolar um sal, para preparar um sal, e para a preparação de um composto
CN103319423B (zh) * 2013-06-28 2015-10-28 江苏师范大学 一种3,7-双芳基-1,5-二氧-3,7-二氮杂环辛烷的合成方法
KR20150082070A (ko) 2014-01-06 2015-07-15 (주)신비넷 위치 인식 시스템 및 그 시스템에서의 위치 인식을 위한 장치 및 방법
EP3059229A1 (en) 2015-02-17 2016-08-24 Evonik Degussa GmbH Method for the epoxidation of an olefin with hydrogen peroxide
CN115054728B (zh) * 2022-07-18 2023-11-07 中国科学院大学宁波华美医院 一种仿生骨组织工程支架材料及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3503939A (en) * 1967-03-29 1970-03-31 Du Pont Polyamides from heterocyclic diamines
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE3112055A1 (de) * 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
DE3902357A1 (de) 1989-01-27 1990-08-02 Hoechst Ag Verwendung von rheniumorganischen verbindungen zur oxidation von c-c-mehrfachbindungen, darauf basierende oxidationsverfahren und neue rheniumorganische verbindungen
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
US5468858A (en) * 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
US5831099A (en) 1995-03-10 1998-11-03 The United States Of America As Represented By The Secretary Of The Army Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same
US5939568A (en) 1997-01-31 1999-08-17 The Scripps Research Institute Accelerated catalysis of olefinic epoxidations
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
HK1042091A1 (zh) * 1999-04-09 2002-08-02 阿斯特拉曾尼卡有限公司 金剛烷衍生物
AUPQ274199A0 (en) 1999-09-09 1999-09-30 Ericsson Australia Pty Ltd Information transmission rate control across a core network
SE9903759D0 (sv) 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
GB0223712D0 (en) * 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate

Also Published As

Publication number Publication date
NO20031413L (no) 2003-05-22
US20050171100A1 (en) 2005-08-04
EP1330462A1 (en) 2003-07-30
AU9250401A (en) 2002-04-15
KR20030032060A (ko) 2003-04-23
BR0114366A (pt) 2003-08-12
SK3862003A3 (en) 2003-10-07
BR0114367A (pt) 2003-12-09
US20040039199A1 (en) 2004-02-26
AU2001292504B2 (en) 2006-09-07
AR030756A1 (es) 2003-09-03
MXPA03002759A (es) 2003-07-28
JP2004510776A (ja) 2004-04-08
NZ524574A (en) 2004-11-26
CA2421776A1 (en) 2002-04-11
PL364047A1 (en) 2004-12-13
RU2003107668A (ru) 2004-11-27
JP2004510775A (ja) 2004-04-08
NO20031414L (no) 2003-05-26
HUP0302288A3 (en) 2004-11-29
CN1468244A (zh) 2004-01-14
CN1468245A (zh) 2004-01-14
NZ524573A (en) 2004-11-26
US7439355B2 (en) 2008-10-21
AU2001292503A1 (en) 2002-04-15
US20090240051A1 (en) 2009-09-24
EE200300131A (et) 2003-06-16
NO20031414D0 (no) 2003-03-27
KR100812920B1 (ko) 2008-03-11
CZ2003923A3 (cs) 2003-08-13
CA2422810A1 (en) 2002-04-11
IL154802A0 (en) 2003-10-31
NO20031413D0 (no) 2003-03-27
IL154803A0 (en) 2003-10-31
WO2002028864A1 (en) 2002-04-11
KR20030032061A (ko) 2003-04-23
CN1793146A (zh) 2006-06-28
US20090036675A1 (en) 2009-02-05
WO2002028863A8 (en) 2003-06-05
WO2002028863A1 (en) 2002-04-11
EP1900741A8 (en) 2010-08-04
IL154803A (en) 2008-03-20
EP1330461A1 (en) 2003-07-30
JP4248873B2 (ja) 2009-04-02
ZA200301757B (en) 2004-02-05
HUP0302288A2 (hu) 2003-10-28
MXPA03002679A (es) 2003-06-24
ZA200302202B (en) 2004-06-28
US6936712B1 (en) 2005-08-30
EP1900741A1 (en) 2008-03-19
CZ294217B6 (cs) 2004-10-13
IS6744A (is) 2003-03-13

Similar Documents

Publication Publication Date Title
CN1243754C (zh) 生产9－氧杂－3,7－二偶氮二环[3.3.1]壬烷的方法
CN1399639A (zh) 用于治疗心律失常的新型氧杂双皮丁化合物
CN101044138A (zh) 吲唑化合物的制备方法
CN1240380C (zh) 吲哚并吡咯并咔唑的相转移催化苷化方法
CN1308332C (zh) 芳基醚的制备方法
KR100848613B1 (ko) 옥사비스피딘의 신규 제조 방법
CN1161335C (zh) 制备取代的哌啶的方法
CN1335317A (zh) 制备吡唑并[4,3－d]嘧啶－7－酮化合物的方法及其中间体
CN1184109A (zh) 对映体纯环烷醇吲哚羧酸和氮杂吲哚羧酸和嘧啶并[1,2－a]－吲哚羧酸及其活性衍生物的制备方法
ZA200502579B (en) Chemical intermediate.
CN100337751C (zh) 应用锆催化剂羟基化β－二羰基化合物的方法
CN101068782A (zh) 合成4－(3－磺酰基苯基)－哌啶类的方法
CN1128536A (zh) 苯并吡喃类化合物及含有这些化合物的药物组合物
HK1049336B (zh) 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体
CN100343240C (zh) 手性2－甲基－4－保护的哌嗪的立体选择性烷基化
CN1360574A (zh) 制备三环氨基醇衍生物的方法
CN1514836A (zh) 制备氧杂双哌啶的新方法
CN1064043C (zh) 1,5苯并硫代氮杂䓬衍生物的制备方法
CN1620425A (zh) 制备氨基甲酸2－(取代苯基)－2－羟基－乙酯的方法
KR20170129898A (ko) 1-(4-히드록시페닐)-4-(4-트리플루오로메톡시페녹시)피페리딘 또는 그 염의 제조방법
CN1902175A (zh) 酰氧基烃基氨基甲酸酯前药及其中间体的合成
CN1819993A (zh) 用于合成hiv－蛋白酶抑制剂的中间体及其制备方法
CN1589272A (zh) 从2－氨甲基－2,3－二氢噁嗪化合物制备2－或－9－氧杂－3 , 7－二氮杂双环(3.3.1)壬烷化合物的方法,其中间体,及制备这些中间体的方法
HK1066004B (en) Method for the preparation of aryl ethers
CN1237967A (zh) 噁唑啉衍生物的制备方法及中间体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060301

Termination date: 20101001